AXIH .0145 and $EGYH .009 these 2 companies are EXTREMELY

New Post Public Reply Private Reply Replies (1) Message Board
AAAAMHIM langlui #53928
AXIH .0145 and $EGYH .009 these 2 companies are EXTREMELY OVERSOLD!

Let's start with AXIH

AXIH is at .0145 but 9 cents us only 40k shares, less than $1200 away? 52wkh .73! LOOK https://t.co/dpxXEg32Zz

AXIH closed down 40% yesterday and was down 47% today. Wait what's the 52 week high of AXIH? Oh yeah it was just 73 CENTS!!!...no biggie. When I alerted RXMD no one was talking about RXMD either. Ran to 8 cents 3 weeks later
It's what I do.

$AXIH Where are the environmentalists with their wallets?

Here we have a green technology that can make a huge and real difference. Where are the environmentalists and do gooders?...nowhere to be found. Quite a shame

The acceptance of this line of products is slowly gaining and the customer base is growing.
The pollution caused by plastic is becoming much more known by the masses and the fact that plastic is never going to compost or break down back into the earth is just plain scary.
The harm it is doing to the water and the earth is horrible. AXIH, on paper, looks like a dream investment given the push towards eco-friendly products. Add in the feature that their products also last longer than conventional options, and that looks like a sure-fire formula for success.

When positive ingredients don't add up to a delicious pie, ya gotta fire the baker and look for someone else to run the show.

Doesn't seem like the CEO has a vested interest in the company. Still, in his next job search, a failed AXIH ain't gonna look good on his resume.

Each day the pps drops another penny. You would think a biggie like Dow, Monsanto or Du Pont would be all over AXIH. All certainly have enough cookies in their cookie jars to make the technology a winner.

Would be a darn shame to watch this puppy die on the vine before it really even got started

I think the risk/reward quotient favors buying rather than selling. If AXIH continues to increase revenues, as they did through nine months in 2014, then the profits (EPS) will eventually come. At this level, I am a buyer, albeit one with fingers crossed. Reason I invest in this company is because they are an EXTREMELY OVERSOLD manufacturing firm with a new technology. Their railroad track is lighter, stronger, and easier to install. And lasts 3 to 5 times as long and is recyclable at the end of its working life. If you believe that they can find a new institutional investor then I would LOAD THE BOAT IMO.

$AXIH can run to 20 cents. Was at 19 cents just 2 months ago and 73 cents a YEAR AGO. People were jumping me on the bid today and have been accumulating heavy the last 3 days. UNKNOWN STOCK. http://www.nasdaq.com/symbol/axih/historical



$EGYH .009 DOWN 99% from last May EXTREMELY OVERSOLD. 1000%+ POTENTIAL. $300 million deal on the table, insiders soaked up 40 million shares, was trading at $1 last yr, news on the way. This is getting LOADED fellas, & is going to bounce like a man running on the moon. 9 page Update on their website, which most penny stocks would have put in a fluffy PR so that theycan DILUTE. Not here with EGYH, ONLY 100 MILLION A\S. YUMMY.

CEO last Monday predicts $5! Only 100 million A\SO with insiders holding 40 MILLION SHARES! WHY do they hold 40% of ALL shares? Traders hold over 41 million shares. Was at $1 last year.

http://www.energyhii.com

PEOPLE DON'T UNDERSTAND THE UNIQUE VALUE HERE. Why would insiders hold 40% of ALL shares 1 may ask...answer could be figured out from a 1st grader. The board is dead on IHUB and there is absolutely no buzz anywhere but that will change soon enough. CEO RELEASED A 9 PAGE UPDATE last Monday, it fell on deaf ears.

When I alerted RXMD at .0016 earlier in the year, the board was dead also it ran to 8 cents 3 weeks later. I alerted GEGU at .002 they laughed, it ran to 4 cents, alerted ERAO at .003 they laughed it ran almost 1000%, alerted $ALKM at .0036 it ran to 3 cents, alerted DTOR .0025 they laughed board dead, it ran 1000%+, alerted VGTL (not done yet) at .002 oh boy did I get HELL for that one, MONEYMADE BROUGHT 13 BASHERS who bashed 24 hours a day from .002-.035 (his whole crew lost BAD on it and he lost all his power and respect for being shady), alerted MGON .0009 it ran to .0086, alerted OMVS pre REVERSE SPLIT at .0013 ...post split would be less than 88 cents AND IT RAN TO $11! And many more. IT'S ALL there just look back at my past posts. The only one that may not be there is RXMD because I was banned from IHUB at the time. You will see RXMD at .002s but my twitter and Facebook friends got .0016. AND SO MANY MORE THIS YEAR ALONE.

I can even take it back to 2011 when I alerted DEGH at .0025 but was ignored for weeks till it ran over 40,000% to $1.35 in 6 months. ALL THE CLUES WERE THERE AND FELL ON DEAF EARS AS I TRIED AND TRIED to get the word out. But I'm FAR FROM A GENIUS. I trade MATHEMATICALLY. CLUES WILL BE IN PLAIN SIGHT AND IGNORED.

EGYH HAS 100 MILLION A\S AND A MEATY 9 PAGE UPDATE. PAGE 7 WAS WHERE THE SUPER ORGANIC MEAT IS.....yet ignored. They'll learn soon.

100 million A\S insiders holding 40 million shares? Sub 1 cent? Not only is EGYH not bloated. IT HAS THE SMALLEST float vs price of 10,000 stocks in the OTC. there is not one with a smaller float vs price that is not a shell. I challenge any I ever to find one and I'll buy it RIGHT NOW
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Papa John's Faces Investor Lawsuit: Class Action Looms

Updated Category News Views 0

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...

Continue Reading
Michigan Roof Inspections: Seasonal Insights That Count

Updated Category News Views 2

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

Continue Reading
AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Updated Category News Views 3

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 3

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Coastal Property Realities: A Deep Dive into Ownership

Updated Category News Views 2

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Continue Reading
NeuralTrust Expands to London as AI Risks Intensify

Updated Category News Views 4

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 1

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading
Ekinops and 1&1 Versatel Fuel a Connectivity Revolution

Updated Category News Views 1

A European Partnership for Modern Connectivity Big players in the telecom industry are joining forces, and it's like watching a seasoned boxer find his perfect sparring partner. Today, Ekinops, a heavyweight in European connectivity, is shaking hands with 1&1 Versatel, a lead puncher in Germany's B2B communications. They're rolling out a unified connectivity portfolio...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 1

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading

Top 5 Most Recently Viewed Articles

Avocados From Mexico Celebrates Certification as Great Employer

Updated Category News Views 51

Avocados From Mexico Achieves Prestigious Great Place To Work Certification Avocados From Mexico is widely recognized not just as the top-selling avocado brand in the United States, but also as a Certified Great Place To Work. This esteemed certification reflects the positive feedback from current employees regarding their experiences within the company. An impressive 97%...

Continue Reading
Etex Shows Stability and Growth Amid Market Challenges in 2025

Updated Category News Views 370

Etex's Strong Half-Year Financial Performance Etex has demonstrated significant resilience in its half-year financial performance, navigating a construction environment that remains largely unpredictable. This strength is highlighted by a steady sales volume and healthy margins, confirming the company's expectations for the period. Overview of Financial Results The...

Continue Reading
First Horizon Bank Becomes Official Partner of NC Courage

Updated Category News Views 111

First Horizon Bank Officially Partners with NC Courage In an exciting development for women's sports, First Horizon Bank (NYSE: FHN) has been named the Official Bank of the North Carolina Courage, marking the start of a multiyear partnership aimed at bolstering community initiatives. This collaboration is an incredible opportunity to enhance support for women's athletics...

Continue Reading
Curis Announces Upcoming Presentations on Emavusertib Research

Updated Category News Views 193

Curis Prepares for Major Presentations at SNO Meeting LEXINGTON, Mass. — Curis, Inc. (NASDAQ: CRIS) is excited to share that the company will participate in the prestigious 30th Annual Meeting of the Society for Neuro-Oncology (SNO). This event is taking place soon, and Curis intends to showcase significant clinical data regarding emavusertib (CA-4948), a promising...

Continue Reading
Novel Approach to PTSD Treatment Unveiled in Recent Study

Updated Category News Views 391

Recent Advancements in PTSD Research Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck LLC have made headlines with the publication of a Phase 3 trial of brexpiprazole combined with sertraline for treating Post-Traumatic Stress Disorder (PTSD) in adults. The findings, appearing in JAMA Psychiatry, indicate a significant improvement in PTSD symptoms...

Continue Reading